Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patiromer vs placebo to maintain RAAS inhibition in CKD with hyperkalemia
2023-503984-41-00Phase 3Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Jun 2023
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hyperkalemia comparing Patiromer (Veltassa) with Placebo (2 arms). Started Jun 2023; status: completed.
02
Drugs
patiromer
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on 2023-503984-41-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-503984-41-00.